Development
BNY Mellon Global Real Return Fund - Class A
DRRAX
NASDAQ
| Weiss Ratings | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BNY Mellon | |||
| Manager/Tenure (Years) | Aron Pataki (9), Andrew Warwick (6) | |||
| Website | http://www.bnymellonim.com/us | |||
| Fund Information | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BNY Mellon Global Real Return Fund - Class A | |||
| Category | Tactical Allocation | |||
| Sub-Category | Flexible Allocation | |||
| Prospectus Objective | Growth and Income | |||
| Inception Date | May 12, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 5.04% | |||
| Dividend | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.76% | |||
| Asset Allocation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 5.38% | |||
| Stock | 53.15% | |||
| U.S. Stock | 32.63% | |||
| Non-U.S. Stock | 20.52% | |||
| Bond | 32.99% | |||
| U.S. Bond | 17.87% | |||
| Non-U.S. Bond | 15.12% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 8.49% | |||
| Price History | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.08% | |||
| 30-Day Total Return | -1.08% | |||
| 60-Day Total Return | -0.89% | |||
| 90-Day Total Return | 1.17% | |||
| Year to Date Total Return | 1.17% | |||
| 1-Year Total Return | 4.21% | |||
| 2-Year Total Return | 12.29% | |||
| 3-Year Total Return | 6.77% | |||
| 5-Year Total Return | 31.41% | |||
| Price | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $15.44 | |||
| 1-Month Low NAV | $15.17 | |||
| 1-Month High NAV | $15.61 | |||
| 52-Week Low NAV | $15.17 | |||
| 52-Week Low NAV (Date) | Jan 13, 2025 | |||
| 52-Week High NAV | $16.56 | |||
| 52-Week High Price (Date) | Dec 06, 2024 | |||
| Beta / Standard Deviation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.81 | |||
| Standard Deviation | 6.09 | |||
| Balance Sheet | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 912.11M | |||
| Operating Ratios | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.18% | |||
| Turnover Ratio | 77.47% | |||
| Performance | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.10% | |||
| Last Bear Market Total Return | -2.90% | |||